Thiem D Phan
Examiner (ID: 7633)
Most Active Art Unit | 3729 |
Art Unit(s) | 3729 |
Total Applications | 2341 |
Issued Applications | 1787 |
Pending Applications | 105 |
Abandoned Applications | 401 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10044445
[patent_doc_number] => 09084828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-21
[patent_title] => 'Oligomer-protein tyrosine kinase inhibitor conjugates'
[patent_app_type] => utility
[patent_app_number] => 14/336764
[patent_app_country] => US
[patent_app_date] => 2014-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29316
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336764
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/336764 | Oligomer-protein tyrosine kinase inhibitor conjugates | Jul 20, 2014 | Issued |
Array
(
[id] => 10541723
[patent_doc_number] => 09266830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-23
[patent_title] => 'Pesticidal arylpyrrolidines'
[patent_app_type] => utility
[patent_app_number] => 14/336853
[patent_app_country] => US
[patent_app_date] => 2014-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 168431
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336853
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/336853 | Pesticidal arylpyrrolidines | Jul 20, 2014 | Issued |
Array
(
[id] => 10996263
[patent_doc_number] => 20160193210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'ANTITUMOR DRUG FOR INTERMITTENT ADMINISTRATION OF FGFR INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 14/905420
[patent_app_country] => US
[patent_app_date] => 2014-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 40196
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905420
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/905420 | ANTITUMOR DRUG FOR INTERMITTENT ADMINISTRATION OF FGFR INHIBITOR | Jul 16, 2014 | Abandoned |
Array
(
[id] => 9917935
[patent_doc_number] => 20150073141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 14/332207
[patent_app_country] => US
[patent_app_date] => 2014-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 84466
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14332207
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/332207 | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto | Jul 14, 2014 | Issued |
Array
(
[id] => 10546904
[patent_doc_number] => 09271499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Pesticidal arylpyrrolidines'
[patent_app_type] => utility
[patent_app_number] => 14/323755
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 163003
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323755
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323755 | Pesticidal arylpyrrolidines | Jul 2, 2014 | Issued |
Array
(
[id] => 9793355
[patent_doc_number] => 20150005299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'PYRROLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/322377
[patent_app_country] => US
[patent_app_date] => 2014-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44830
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14322377
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/322377 | Pyrrole compounds that modulate HSP90 activity | Jul 1, 2014 | Issued |
Array
(
[id] => 10906259
[patent_doc_number] => 20140309273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'COMPOUNDS AND METHODS OF TREATING OBESITY'
[patent_app_type] => utility
[patent_app_number] => 14/314228
[patent_app_country] => US
[patent_app_date] => 2014-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17269
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14314228
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/314228 | Compounds and methods of treating obesity | Jun 24, 2014 | Issued |
Array
(
[id] => 9898745
[patent_doc_number] => 20150053944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'ORGANIC LIGHT-EMITTING DEVICE'
[patent_app_type] => utility
[patent_app_number] => 14/309298
[patent_app_country] => US
[patent_app_date] => 2014-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18539
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14309298
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/309298 | ORGANIC LIGHT-EMITTING DEVICE | Jun 18, 2014 | Abandoned |
Array
(
[id] => 9772654
[patent_doc_number] => 20140296317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => '4R,5S-ENANTIOMER OF 2-(5-METHYL-2-OXO-4-PHENYL-PYRROLIDIN-1-YL)-ACETAMIDE WITH NOOTROPIC ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/305382
[patent_app_country] => US
[patent_app_date] => 2014-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3487
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14305382
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/305382 | 4R,5S-ENANTIOMER OF 2-(5-METHYL-2-OXO-4-PHENYL-PYRROLIDIN-1-YL)-ACETAMIDE WITH NOOTROPIC ACTIVITY | Jun 15, 2014 | Abandoned |
Array
(
[id] => 9757444
[patent_doc_number] => 20140288142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'NITRIC OXIDE DONOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/300049
[patent_app_country] => US
[patent_app_date] => 2014-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71082
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14300049
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/300049 | Nitric oxide donor compounds | Jun 8, 2014 | Issued |
Array
(
[id] => 10768963
[patent_doc_number] => 20160115120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'METHOD FOR THE CONTROLLED HYDROFORMYLATION AND ISOMERIZATION OF A NITRILE/ESTER/OMEGA UNSATURATED FATTY ACID'
[patent_app_type] => utility
[patent_app_number] => 14/896247
[patent_app_country] => US
[patent_app_date] => 2014-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12106
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896247
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/896247 | METHOD FOR THE CONTROLLED HYDROFORMYLATION AND ISOMERIZATION OF A NITRILE/ESTER/OMEGA UNSATURATED FATTY ACID | Jun 5, 2014 | Abandoned |
Array
(
[id] => 11642144
[patent_doc_number] => 09663499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Small molecule inhibitors of fibrosis'
[patent_app_type] => utility
[patent_app_number] => 14/895813
[patent_app_country] => US
[patent_app_date] => 2014-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 42666
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14895813
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/895813 | Small molecule inhibitors of fibrosis | Jun 4, 2014 | Issued |
Array
(
[id] => 9757614
[patent_doc_number] => 20140288315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'OLIGOMER-CONTAINING PYRROLIDINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/297149
[patent_app_country] => US
[patent_app_date] => 2014-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14192
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14297149
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/297149 | Oligomer-containing pyrrolidine compounds | Jun 4, 2014 | Issued |
Array
(
[id] => 10574063
[patent_doc_number] => 09296690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-29
[patent_title] => 'Method for inhibiting differentiation of osteoclast and pharmaceutical composition comprising thereof'
[patent_app_type] => utility
[patent_app_number] => 14/293879
[patent_app_country] => US
[patent_app_date] => 2014-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15778
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 496
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14293879
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/293879 | Method for inhibiting differentiation of osteoclast and pharmaceutical composition comprising thereof | Jun 1, 2014 | Issued |
Array
(
[id] => 10774714
[patent_doc_number] => 20160120870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'THE PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION COMPRISING RIVAROXABAN'
[patent_app_type] => utility
[patent_app_number] => 14/893086
[patent_app_country] => US
[patent_app_date] => 2014-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5767
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893086
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/893086 | THE PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION COMPRISING RIVAROXABAN | May 27, 2014 | Abandoned |
Array
(
[id] => 12015740
[patent_doc_number] => 09808427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Swallowable N-acetylcysteine tablets'
[patent_app_type] => utility
[patent_app_number] => 14/893100
[patent_app_country] => US
[patent_app_date] => 2014-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4296
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893100
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/893100 | Swallowable N-acetylcysteine tablets | May 26, 2014 | Issued |
Array
(
[id] => 9719628
[patent_doc_number] => 20140255327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'NOVEL AMIDE DERIVATIVE AND WHITENING AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/287899
[patent_app_country] => US
[patent_app_date] => 2014-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10682
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14287899
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/287899 | Amide derivative and whitening agent | May 26, 2014 | Issued |
Array
(
[id] => 10749693
[patent_doc_number] => 20160095843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/892613
[patent_app_country] => US
[patent_app_date] => 2014-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89577
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892613
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/892613 | PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | May 25, 2014 | Abandoned |
Array
(
[id] => 10761851
[patent_doc_number] => 20160108004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS USING MENTHOL, LINALOOL AND/OR ICILIN'
[patent_app_type] => utility
[patent_app_number] => 14/892004
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3573
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892004
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/892004 | TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS USING MENTHOL, LINALOOL AND/OR ICILIN | May 22, 2014 | Abandoned |
Array
(
[id] => 10761852
[patent_doc_number] => 20160108005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'TREATMENT OR PREVENTION OF DEPRESSION USING MENTHOL AND/OR ICILIN'
[patent_app_type] => utility
[patent_app_number] => 14/892016
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2988
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892016
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/892016 | TREATMENT OR PREVENTION OF DEPRESSION USING MENTHOL AND/OR ICILIN | May 22, 2014 | Abandoned |